Nouryon advances South America growth strategy with new customer experience and innovation center in Brazil for its home and personal care business GlobeNewswire December 10, 2025 Global special chemical leader Nouryon today announced a major milestone with the groundbreaking ceremony for a new dedicated home and personal care customer experience and innovation center in Itupeva, Brazil. […]

MediWound Reports New Clinical Data Demonstrating NexoBrid(R)'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries GlobeNewswire December 10, 2025 MediWound Reports New Clinical Data Demonstrating NexoBrid(R)'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries Prospective clinical data show NexoBrid(R) removes embedded particles in friction and blast wounds, reducing pigmented wound surface

UNISYNC Corp. Reports Fiscal 2025 Results GlobeNewswire December 10, 2025 TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX:”UNI”) (OTC:”USYNF“) today announced its financial results for the twelve months ended September 30, 2025, highlighted by a return to profitability, a second consecutive year of gross margin improvement, and a growing base of contracted

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration GlobeNewswire December 10, 2025 MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncology, to develop novel clinical applications

BioStem Technologies(R) to Debut American Amnion(TM) at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our Veterans GlobeNewswire December 10, 2025 POMPANO BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company

PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets GlobeNewswire December 10, 2025 $47.5 million Series A financing led by Samsara Biocapital and Lightstone Ventures to advance PsiThera's growing pipeline, starting with multiple clinically validated TNF superfamily preclinical programs Biotech veteran Eric Shaff appointed CEO

Photronics Reports Full Year and Fourth Quarter Fiscal 2025 Results GlobeNewswire December 10, 2025 BROOKFIELD, Conn., Dec. 10, 2025 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its full year and fourth quarter of fiscal year 2025 ended October 31, 2025. Commenting on the

OTC Markets Group Welcomes Vizsla Royalties Corp. to OTCQX GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vizsla Royalties Corp. (TSX-V: VROY; OTCQX: VROYF), a precious metals focused royalty company, has qualified

Tecnoglass Announces Fourth Quarter 2025 Dividend GlobeNewswire December 10, 2025 Miami, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared

According to MarketsandMarkets™, the Railway Testing Market is projected to grow from USD 3.91 billion in 2025 to USD 5.34 billion by 2032, registering a CAGR of 4.6%. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse 200 market data Tables and 65 Figures spread through 350 Pages and in-depth TOC on “Railway Testing Market – Global Forecast to 2032” Railway Testing